Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055260 · ClinicalTrials.gov registry record · NA
Low Intensity Blood Flow Restriction Training Study
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03055260: Completed NA study, sponsored by University of Minnesota.
NCT03055260 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03055260, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The particpant will complete baseline testing by measuring subjects' quadriceps muscle thickness (cm) via ultrasound technology, as well as have them complete a one repetition maximum (1RM) test on the leg press machine and an isometric knee extension using a dynamometer - strength measures will be calculated for both right and left legs. After baseline testing, subjects will complete 6 weeks of the testing protocol that will consist of leg press exercises at 30% of their 1RM. Subjects will be randomized to either wear a cuff that partially restricts blood flow to the limb (Study Group), or to wear a cuff that does not restrict blood flow (Control Group). Exercises will be completed 2x/week and will take approximately 10 total minutes (5 for warm up, 5 for testing protocol) per session. After 6 weeks, muscle thickness, leg press 1RM, and quadriceps extension strength will be re-tested and compared to the initial measurements.
Primary Outcome
One repetition maximum on the single leg press. Isometric quadriceps extension strength.
Interventions
- DEVICE Blood flow restriction cuff
- DEVICE Blood Flow restriction Cuff-Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03055260 record still lists
NCT03055260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood flow restriction cuff is the first listed.
NCT03055260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03055260 about?
NCT03055260 is a clinical study titled "Low Intensity Blood Flow Restriction Training Study". The particpant will complete baseline testing by measuring subjects' quadriceps muscle thickness (cm) via ultrasound technology, as well as have them complete a one repetition maximum (1RM) test on the leg press machine and an isometric knee extension using a dynamometer - strength measures will be ...
What is the current status of trial NCT03055260?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-05-23. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03055260?
The interventions under investigation include: Blood flow restriction cuff (DEVICE), Blood Flow restriction Cuff-Placebo (DEVICE).
Who is sponsoring clinical trial NCT03055260?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03055260's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI